N

Natural Beauty Bio-Technology Ltd
HKEX:157

Watchlist Manager
Natural Beauty Bio-Technology Ltd
HKEX:157
Watchlist
Price: 0.475 HKD
Market Cap: HK$951m

Balance Sheet

Balance Sheet Decomposition
Natural Beauty Bio-Technology Ltd

Balance Sheet
Natural Beauty Bio-Technology Ltd

Rotate your device to view
Balance Sheet
Currency: HKD
Dec-2002 Dec-2003 Dec-2004 Dec-2005 Dec-2006 Dec-2007 Dec-2008 Dec-2009 Dec-2010 Dec-2011 Dec-2012 Dec-2013 Dec-2014 Dec-2015 Dec-2016 Dec-2017 Dec-2018 Dec-2019 Dec-2020 Dec-2021 Dec-2022 Dec-2023 Dec-2024 Dec-2025
Assets
Cash & Cash Equivalents
217
170
236
339
356
589
546
559
576
558
432
507
583
503
429
289
181
146
162
193
169
167
117
112
Cash
217
170
236
339
356
589
546
559
576
558
432
507
583
503
429
289
181
146
162
193
169
167
117
112
Short-Term Investments
88
68
94
27
28
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Total Receivables
101
131
125
127
145
85
76
74
35
46
43
101
58
47
79
102
75
101
116
116
79
83
72
122
Accounts Receivables
101
131
125
78
86
59
65
59
19
26
23
84
51
41
73
98
71
99
114
115
76
77
68
121
Other Receivables
0
0
0
49
59
26
11
15
16
20
20
18
7
6
6
4
4
3
2
1
3
6
4
1
Inventory
53
63
56
57
64
71
101
89
47
40
67
47
45
47
50
85
74
85
103
121
99
78
81
95
Other Current Assets
0
0
0
15
21
14
17
12
10
11
12
12
10
13
9
16
18
27
20
20
18
16
19
25
Total Current Assets
459
431
511
563
613
759
741
735
667
655
555
667
696
610
566
492
348
360
400
450
365
343
289
354
PP&E Net
362
353
353
179
174
218
231
218
232
261
273
257
224
187
174
199
218
345
370
417
238
271
274
513
PP&E Gross
362
353
353
179
174
218
231
218
232
261
273
257
224
187
174
199
218
345
370
417
238
271
274
513
Accumulated Depreciation
54
78
103
114
131
142
119
117
96
104
129
167
195
173
184
219
220
240
259
274
271
274
265
279
Intangible Assets
5
3
2
1
0
0
0
0
0
0
0
0
0
0
0
0
17
15
14
6
0
0
0
0
Goodwill
11
24
17
14
23
25
26
26
27
28
28
28
28
27
26
27
31
27
29
30
26
25
0
0
Note Receivable
0
9
5
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
17
Long-Term Investments
12
12
7
167
170
14
10
9
5
5
6
6
6
7
7
8
8
8
9
10
229
218
190
15
Other Long-Term Assets
12
10
5
14
19
17
19
13
10
10
23
23
24
58
50
52
57
2
10
18
15
16
20
26
Other Assets
11
24
17
14
23
25
26
26
27
28
28
28
28
27
26
27
31
27
29
30
26
25
0
0
Total Assets
862
N/A
841
-2%
900
+7%
938
+4%
998
+6%
1 032
+3%
1 026
-1%
999
-3%
941
-6%
959
+2%
884
-8%
982
+11%
978
0%
889
-9%
822
-7%
778
-5%
679
-13%
757
+12%
832
+10%
930
+12%
872
-6%
872
+0%
773
-11%
926
+20%
Liabilities
Accounts Payable
83
54
56
17
17
22
14
12
13
22
18
21
19
15
21
22
21
26
26
15
10
21
26
36
Accrued Liabilities
0
0
0
16
9
13
10
9
8
9
0
55
63
56
75
36
42
37
52
55
35
30
35
40
Short-Term Debt
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Current Portion of Long-Term Debt
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
22
59
95
119
172
74
187
Other Current Liabilities
17
19
30
74
82
70
134
98
125
124
108
105
110
73
67
58
63
72
67
73
86
60
53
56
Total Current Liabilities
99
73
85
106
107
105
158
119
146
155
126
181
191
144
163
116
126
158
205
238
251
283
188
319
Long-Term Debt
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
31
16
34
24
15
138
132
Deferred Income Tax
0
0
0
0
0
0
0
0
2
5
0
0
0
0
1
6
0
0
0
0
0
0
0
0
Minority Interest
20
10
10
7
0
6
6
1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Other Liabilities
8
8
10
11
11
12
12
12
11
10
10
13
13
12
4
6
1
1
1
0
0
0
0
0
Total Liabilities
127
N/A
91
-29%
105
+16%
124
+18%
119
-4%
123
+3%
176
+44%
131
-26%
158
+21%
171
+8%
136
-20%
194
+43%
204
+5%
156
-23%
168
+7%
127
-24%
127
0%
190
+49%
221
+16%
273
+23%
275
+1%
298
+8%
325
+9%
452
+39%
Equity
Common Stock
200
200
200
200
200
200
200
200
200
200
200
200
200
200
200
200
200
200
200
200
200
200
200
200
Retained Earnings
205
218
236
273
316
310
548
561
442
427
378
408
406
409
368
311
243
265
272
308
277
262
159
169
Additional Paid In Capital
337
337
337
337
337
337
38
41
41
41
41
41
41
41
41
41
41
41
41
35
29
29
29
29
Unrealized Security Profit/Loss
10
14
17
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
29
29
29
29
Other Equity
18
18
6
4
26
63
64
66
100
120
129
139
127
82
46
98
68
62
98
115
62
54
31
47
Total Equity
734
N/A
750
+2%
795
+6%
814
+2%
879
+8%
910
+4%
850
-7%
868
+2%
783
-10%
788
+1%
748
-5%
788
+5%
774
-2%
733
-5%
655
-11%
651
-1%
552
-15%
568
+3%
611
+8%
658
+8%
597
-9%
575
-4%
448
-22%
474
+6%
Total Liabilities & Equity
862
N/A
841
-2%
900
+7%
938
+4%
998
+6%
1 032
+3%
1 026
-1%
999
-3%
941
-6%
959
+2%
884
-8%
982
+11%
978
0%
889
-9%
822
-7%
778
-5%
679
-13%
757
+12%
832
+10%
930
+12%
872
-6%
872
+0%
773
-11%
926
+20%
Shares Outstanding
Common Shares Outstanding
2 000
2 000
2 000
2 000
2 000
2 000
2 001
2 002
2 002
2 002
2 002
2 002
2 002
2 002
2 002
2 002
2 002
2 002
2 002
2 002
2 002
2 002
2 002
2 002
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett